Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase Ii Study
AuthID
P-00W-G1F
P-00W-G1F
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service